Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 42806-601

This is a drug interaction table that lists drugs that may interact with CYP2D6 and CYP206 enzymes in the body. The table shows which drugs may cause a PK fold change, indicating whether they may increase or decrease the concentration of the drug in the body. For CYP2D6 EM's, the drugs Ethanol, Diazepam, Cimetidine, and Ketoconazole are listed as having clinical significance and may require dose adjustment, monitoring, or cautious use in patients with hypertension, hepatic dysfunction, or elderly patients. Meanwhile, for CYP206 PM's, only Ketoconazole is listed, and Cmax levels should be monitored cautiously. The table also includes analytes for venlafaxine, and the table recommends avoiding concurrent use, use with caution, or no dose adjustment, depending on the drug-enzyme interaction.*

This appears to be a list of drugs with some related information such as their active agents, PKFold change and 90% recommend dosage. However, the text is not well-organized and it is difficult to determine a useful description.*

This appears to be a table that provides recommendations for changes in medication dosage for individuals with specific conditions or characteristics. The table mentions special populations with hepatic and renal impairments, as well as CYP206 polymorphism and age and gender differences. It lists various Analytes and their fold change and 90% CI. Based on these factors, the recommendation is to reduce the medication dosage for some individuals or consider individualization of dosing.*

This is a medication for which the usual dosage can be found on NDC 42806-601-30. Each capsule of this medication contains Venlafaxine Hydrochloride, an extended-release drug. The medication should be stored in a container that is light resistant, and the recommended temperature range is from 20°C to 25°C. The medication should be kept out of the reach of children, and a medication guide should be printed and distributed along with the medication to each patient. The medication is distributed by Epic Pharma, LLC and manufactured by Yichang Humanwell Oral Solid Dosage Plant in China.*

This is prescribing information for Venlafaxine Hydrochloride Extended-Release capsules, with dosing information available on the NDC 42806-601-09 package. The capsules should be stored at 20-25°C (68-77°F) with excursions permitted up to 15-30°C (59-86°F) and should be kept in a tight, light-resistant container out of reach of children. The medication guide for Nenlataxine Hydrochloride-ER is available at epic-pharma.com, and the capsules are distributed by Eplc Pharma, LLC, and manufactured by Yichang Humanwell Oral Solld Dosage Plant in China.*

This is a medication with an extended-release formula, which comes in capsules. The usual dosage information can be found on the NDC 42806-602-30. Each capsule contains Enlafaxine Eneacho HCl. It is important to keep it in a controlled temperature environment and out of the reach of children. The medication guide can be printed on the epic-pharma.com website. The medication has a tamper-resistant closure and should be dispensed by a pharmacist with an accompanying Medication Guide. This medication is manufactured by Yichang Humanwell Oral Solid Dosage Plant in China and distributed by Epic Pharma, LLC, in Laurelton, NY.*

This appears to be prescribing information for an extended-release medication containing venlafaxine hydrochloride, with a usual dosage of 75 mg. It is important to keep the medication in a child-resistant, light-resistant container at temperatures between 15-30°C. The medication should be dispensed by a pharmacist with an accompanying medication guide for each patient. The medication is manufactured by Yichang Humanwell Oral Solid Dosage Plant in China and is distributed by Epic Pharma, LLC.*

This is a label describing the dosage of Venlafaxine Hydrochloride Extended-Release Capsules. The recommended dosage is mentioned along with the chemical composition, storage instructions, and other relevant details. The label also provides a link to a medication guide for reference. The label is intended for healthcare professionals and should not be used without a prescription.*

This is a medication called Venlafaxine Hydrochloride Extended-Release Capsules, with a usual dosage indicated in the accompanying prescription information. It should be stored between 20 to 25°C (68 to 77°F) and dispensed in a tight, light-resistant container with a child-resistant closure. The medication guide should be provided to each patient. Each capsule contains 150mg of venlafaxine hydrochloride, with a total of 90 capsules in the package. The medication is manufactured in Yichang, Hubel, China and distributed by Eplc Pharma, LLC.*

The description is: "venlafaxine hydrochloride".*